![Gilbert Wagener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilbert Wagener
Chief Tech/Sci/R&D Officer at
PHARNEXT SCA
Profile
Gilbert Wagener is currently the Chief Medical Officer at Pharnext SA since 2023.
Prior to this, he held the same position at Cell2B - Advanced Therapeutics SA and Ixaka Ltd. Dr. Wagener holds a doctorate from Erasmus University Rotterdam and Philipps University of Marburg, and an MBA from the University of Basel.
Gilbert Wagener active positions
| Companies | Position | Start |
|---|---|---|
| PHARNEXT SCA | Chief Tech/Sci/R&D Officer | 2023-06-14 |
Former positions of Gilbert Wagener
| Companies | Position | End |
|---|---|---|
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Chief Tech/Sci/R&D Officer | - |
Cell2B - Advanced Therapeutics SA
 Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Develops stem cell therapies and pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Gilbert Wagener
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Cell2B - Advanced Therapeutics SA
Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Develops stem cell therapies and pharmaceuticals | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
- Stock Market
- Insiders
- Gilbert Wagener
